MedPath
TGA Approval

FYCOMPA perampanel (as hemisesquihydrate) 2 mg/4 mL oral suspension (332505)

332505

FYCOMPA perampanel (as hemisesquihydrate) 2 mg/4 mL oral suspension

Eisai Australia Pty Ltd

February 16, 2021

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2014-CMI-02671-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2014-PI-02011-1

Active Ingredients

perampanel hemisesquihydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

FYCOMPA perampanel (as hemisesquihydrate) 2 mg/4 mL oral suspension (332505) - TGA 批准文号 | MedPath